- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...
New eye drops can help aging people see better – an optometrist explains how Vuity treats presbyopia
When people get into their 40s and beyond, their close-up vision starts to worsen. For many people, cranking up the font size on a phone or maxing out the brightness on a computer is the only way to ...
Add Yahoo as a preferred source to see more of our stories on Google. Glasses could be a thing of the past for millions of Americans thanks to a new prescription eye drop. Vuity, which was approved by ...
The phase 3 VIRGO study evaluated the efficacy and safety of Vuity in adults aged 40 to 55 years of age with presbyopia. Positive topline results were announced from a phase 3 study evaluating the ...
Please provide your email address to receive an email when new articles are posted on . With a new pharmaceutical treatment option, my conversations with presbyopic patients have gotten a lot more ...
VUITY is the first and only eye drop to treat presbyopia, or age-related blurry near vision, in adults and is FDA-approved for once-daily administration In the VIRGO trial evaluating twice-daily ...
When people get into their 40s and beyond, their close-up vision starts to worsen. For many people, cranking up the font size on a phone or maxing out the brightness on a computer is the only way to ...
NORTH CHICAGO, Ill., Dec. 9, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that VUITY™ (pilocarpine HCl ophthalmic solution) 1.25%, the first and only eye drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results